Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 8897
116th Congress(2019-2020)
To direct the Secretary of Defense to carry out a program for the development of rapid and cost-effective medical countermeasures to pandemics, and for other purposes.
Introduced
Introduced
Introduced in House on Dec 8, 2020
Overview
Text
Introduced in House 
Dec 8, 2020
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Dec 8, 2020)
Dec 8, 2020
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 8897 (Introduced-in-House)


116th CONGRESS
2d Session
H. R. 8897


To direct the Secretary of Defense to carry out a program for the development of rapid and cost-effective medical countermeasures to pandemics, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

December 8, 2020

Mr. Gosar introduced the following bill; which was referred to the Committee on Armed Services

A BILL

To direct the Secretary of Defense to carry out a program for the development of rapid and cost-effective medical countermeasures to pandemics, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Pandemic Prevention Platform.

(a) Designation.—The Secretary of Defense shall designate a lead within the Department of Defense to implement and advance a program for the development of rapid and cost-effective medical countermeasures to pandemics.

(b) Objectives.—The Secretary shall ensure that the program carries out the following within 60 days of identifying a virus or other pathogen that may cause a pandemic with the goal of reducing this time frame to 28 days:

(1) Grow the virus or other pathogen.

(2) Identify an antibody or biologic product that targets the virus or other pathogen for use in a medical countermeasure.

(3) Evolve the antibody or biologic product for increased potency.

(4) Clinical grade product manufacturing.

(5) Deliver the product to patients to induce protection in fewer than three days following administration.

(6) Any other objective the Secretary of Defense deems necessary.

(c) Collaboration and information sharing.—In carrying out this section, the Secretary of Defense—

(1) may collaborate with such Secretaries pursuant to the National Biodefense Strategy under section 1086 of the National Defense Authorization Act for Fiscal Year 2017 (6 U.S.C. 104);

(2) shall ensure that information from the program is shared with such Secretaries pursuant to the National Biodefense Strategy under section 1086 of the National Defense Authorization Act for Fiscal Year 2017 (6 U.S.C. 104); and

(3) through regular, structured, and close consultation with the Secretary of Health and Human Services and the Secretary of Homeland Security, shall ensure that the activities of the Department of Defense in carrying out the program are coordinated with, complement, and do not unnecessarily duplicate activities of other Federal agencies pursuant to the National Biodefense Strategy under section 1086 of the National Defense Authorization Act for Fiscal Year 2017 (6 U.S.C. 104).